13F-HR filed by Tri Locum Partners LP
Tri Locum Partners LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 17:23:09 UTC, with 18 holding rows worth $506,138,439.
- Accession
- 0001826434-26-000007
- Filer
- CIK 1826434
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 18 entries on the cover page, a total value of $506,138,439 stated on the cover page (in dollars after the unit check, H1), rows summing to $506,138,439 with VALUE read as dollars as filed, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 132,896 | $69,479,358 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 51,015 | $59,028,436 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,223,725 | $48,459,510 | dollars as filed | |
| AMNEAL PHARMACEUTICALS INC | 03168L105 | COM STK CL A | 2,326,733 | $46,860,403 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 489,400 | $42,230,326 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 160,321 | $37,117,518 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 30,399 | $29,149,905 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 118,384 | $26,971,427 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 143,338 | $26,430,094 | dollars as filed | |
| Johnson & Johnson | 478160104 | COM | 73,559 | $19,474,010 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 410,236 | $18,805,218 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 33,000 | $17,882,370 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 33,668 | $16,967,325 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 202,618 | $16,112,183 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 177,225 | $15,604,661 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 40,019 | $8,214,300 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 144,406 | $5,496,092 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 90,107 | $1,855,303 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001826434-26-000007 | this filing | 2026-11-16 |